company background image
530199 logo

Themis Medicare BSE:530199 Stock Report

Last Price

₹261.85

Market Cap

₹24.2b

7D

-6.6%

1Y

19.6%

Updated

24 Dec, 2024

Data

Company Financials

Themis Medicare Limited

BSE:530199 Stock Report

Market Cap: ₹24.2b

530199 Stock Overview

Manufactures and sells pharmaceutical products in India and internationally. More details

530199 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends2/6

Rewards

Earnings have grown 16.9% per year over the past 5 years

Risk Analysis

No risks detected for 530199 from our risk checks.

My Notes

Capture your thoughts, links and company narrative

Themis Medicare Limited Competitors

IOL Chemicals and Pharmaceuticals

BSE:524164

₹24.0b

Amrutanjan Health Care

BSE:590006

₹21.1b

TTK Healthcare

BSE:507747

₹20.4b

Novartis India

BSE:500672

₹23.5b

Price History & Performance

Summary of share price highs, lows and changes for Themis Medicare
Historical stock prices
Current Share Price₹261.85
52 Week High₹313.65
52 Week Low₹182.45
Beta0.48
1 Month Change-9.55%
3 Month Change-11.69%
1 Year Change19.62%
3 Year Change181.80%
5 Year Change719.43%
Change since IPO11,829.39%

Recent News & Updates

Recent updates

Shareholder Returns

530199IN PharmaceuticalsIN Market
7D-6.6%0.6%-4.2%
1Y19.6%40.2%19.4%

Return vs Industry: 530199 underperformed the Indian Pharmaceuticals industry which returned 40.2% over the past year.

Return vs Market: 530199 matched the Indian Market which returned 19.4% over the past year.

Price Volatility

Is 530199's price volatile compared to industry and market?
530199 volatility
530199 Average Weekly Movement5.7%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 530199 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 530199's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19521,509Sachin Patelwww.themismedicare.com

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics. It also offers anti-inflammatory drugs and other drugs.

Themis Medicare Limited Fundamentals Summary

How do Themis Medicare's earnings and revenue compare to its market cap?
530199 fundamental statistics
Market cap₹24.25b
Earnings (TTM)₹529.90m
Revenue (TTM)₹4.20b

45.5x

P/E Ratio

5.7x

P/S Ratio

Is 530199 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
530199 income statement (TTM)
Revenue₹4.20b
Cost of Revenue₹1.51b
Gross Profit₹2.70b
Other Expenses₹2.17b
Earnings₹529.90m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 14, 2025

Earnings per share (EPS)5.76
Gross Margin64.13%
Net Profit Margin12.61%
Debt/Equity Ratio19.8%

How did 530199 perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

9%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 13:15
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Themis Medicare Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anil BurraFirstCall Research